News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 06, 2020, 22:26 ET U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite

Endo International plc (NASDAQ: ENDP) today announced that it received U.S. Food and Drug Administration (FDA) approval of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of...


Jun 17, 2020, 07:30 ET New Harris Poll Survey Shows 60% of Women Surveyed Feel It's Their Fault They Have Cellulite

Sixty percent (60%) of women surveyed feel it's their fault they have cellulite and 57% feel judged for their cellulite,i according to new Harris Poll survey results released today by Endo Aesthetics ...


Jun 16, 2020, 17:00 ET Endo to Announce Second-Quarter 2020 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2020 financial results on August 6, 2020 and members of its senior management team will host a conference call and webcast at...


Jun 15, 2020, 07:30 ET Endo International plc Announces Final Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations

More Than 97% Of Notes Sought Were Tendered And Accepted Thereby Extending More Than $2.7 Billion Of Endo International plc's Near-Term Debt Maturities Requisite Consents Obtained Providing Endo...


May 29, 2020, 08:00 ET Endo International plc Announces Early Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations

Endo International plc (the "Company") (NASDAQ: ENDP) announced today the early tender results of the previously announced Exchange Offers and Consent Solicitations (each as defined below) by wholly...


May 14, 2020, 17:00 ET Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, ...


May 14, 2020, 07:38 ET Endo International plc Announces Proposed Exchange Offers And Consent Solicitations

Endo International plc (the "Company") (NASDAQ:ENDP) announced today that its wholly owned subsidiaries, Par Pharmaceutical, Inc., a New York corporation ("PPI"), Endo Designated Activity Company, a...


Apr 16, 2020, 17:00 ET Endo to Announce First Quarter 2020 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first–quarter 2020 financial results on May 7, 2020 and members of its senior management team will host a conference call and webcast at 8:00am ...


Feb 19, 2020, 16:20 ET Endo Names Blaise Coleman President and Chief Executive Officer

Endo International plc (NASDAQ: ENDP) today announced that Blaise Coleman, who has served as the Company's Executive Vice President and Chief Financial Officer since 2016, will succeed Paul...


Feb 19, 2020, 16:20 ET Endo Appoints Mark G. Barberio to Board of Directors

Endo International plc (NASDAQ: ENDP) today announced that its Board of Directors has appointed Mark G. Barberio to serve as a director, effective February 19, 2020. Mr. Barberio has also been...


Jan 27, 2020, 16:20 ET Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Allergan's Carafate®...


Jan 24, 2020, 17:00 ET Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2019 financial results on February 26, 2020 and members of its senior management team will host a conference call...


Jan 10, 2020, 11:50 ET Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Par Pharmaceutical, Inc. (collectively, the "Settling Parties") have executed a Settlement...


Dec 17, 2019, 17:00 ET Endo to Participate at J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 13, 2020 at 3:30 ...


Dec 10, 2019, 08:06 ET Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has received approval for and launched generic Afinitor® (everolimus) 2.5 mg, 5 mg ...


Nov 22, 2019, 17:00 ET Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton,...


Nov 19, 2019, 16:10 ET Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc (NASDAQ: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the original Biologics License Application (BLA) for collagenase...


Nov 04, 2019, 16:15 ET Endo Reports Third-Quarter 2019 Financial Results

Endo International plc (NASDAQ: ENDP) today reported third-quarter 2019 financial results, including: Revenues of $729 million decreased 2% compared to third-quarter 2018 revenues of $745 million....


Nov 04, 2019, 16:15 ET Endo Implements CEO Succession Plan

Endo International plc (NASDAQ: ENDP) today announced that Paul V. Campanelli, President and Chief Executive Officer has notified the Board of Directors ("Board") of his intention to retire and the...


Oct 28, 2019, 07:30 ET Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation

Endo International plc (NASDAQ: ENDP) announced that Endo Aesthetics launched a "Redefining Scientific Artistry" campaign at the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) ...


Oct 25, 2019, 07:30 ET Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)

Endo International plc (NASDAQ: ENDP) today announced that five new studies of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of Peyronie's disease will be presented as poster...


Oct 24, 2019, 07:30 ET Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that it will present data on the use of a standing MRI as compared to prone MRI for the evaluation of cellulite at the upcoming Annual Meeting of ...


Oct 23, 2019, 07:30 ET Movapo® (apomorphine hydrochloride) for Patients with Advanced Parkinson's Disease Now Reimbursed in Most Canadian Provinces

Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), today announced that patients diagnosed with advanced Parkinson's disease (PD) living in Alberta, Manitoba, New Brunswick,...